June 2016 Opinion The Public Health Implications of the FDA Update to the Medication Abortion Label Rachel K. Jones and Heather D. Boonstra Health Affairs Blog
June 2016 Infographic Twice as many abortion patients are eligible for medication abortion following the 2016 FDA label change
June 2016 Policy Analysis How Might State Innovations in Health Reform Affect Sexual and Reproductive Health Care? Adam Sonfield Guttmacher Policy Review
May 2016 Policy Analysis Countering Zika Globally and in the United States: Women’s Right to Self-Determination Must Be Central Joerg Dreweke Guttmacher Policy Review
